- Home
- CRON vs LENZ Comparison
CRON vs LENZ Comparison
Compare CRON & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRON
- LENZ
- Stock Information
- Founded
- CRON N/A
- LENZ 2019
- Country
- CRON Canada
- LENZ United States
- Employees
- CRON N/A
- LENZ N/A
- Industry
- CRON Medicinal Chemicals and Botanical Products
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- CRON Health Care
- LENZ Health Care
- Exchange
- CRON Nasdaq
- LENZ Nasdaq
- Market Cap
- CRON 684.7M
- LENZ 819.1M
- IPO Year
- CRON N/A
- LENZ 2021
- Fundamental
- Price
- CRON $1.86
- LENZ $29.94
- Analyst Decision
- CRON
- LENZ Strong Buy
- Analyst Count
- CRON 0
- LENZ 5
- Target Price
- CRON N/A
- LENZ $41.80
- AVG Volume (30 Days)
- CRON 1.6M
- LENZ 274.7K
- Earning Date
- CRON 08-07-2025
- LENZ 05-07-2025
- Dividend Yield
- CRON N/A
- LENZ N/A
- EPS Growth
- CRON N/A
- LENZ N/A
- EPS
- CRON 0.13
- LENZ N/A
- Revenue
- CRON $124,589,000.00
- LENZ N/A
- Revenue This Year
- CRON $25.49
- LENZ N/A
- Revenue Next Year
- CRON $7.45
- LENZ $544.79
- P/E Ratio
- CRON $14.59
- LENZ N/A
- Revenue Growth
- CRON 33.92
- LENZ N/A
- 52 Week Low
- CRON $1.60
- LENZ $16.28
- 52 Week High
- CRON $2.54
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- CRON 38.80
- LENZ 54.67
- Support Level
- CRON $1.92
- LENZ $27.91
- Resistance Level
- CRON $2.01
- LENZ $30.76
- Average True Range (ATR)
- CRON 0.05
- LENZ 2.09
- MACD
- CRON -0.01
- LENZ -0.14
- Stochastic Oscillator
- CRON 0.00
- LENZ 38.41
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.